Indication
Peripheral Arterial Occlusive Disease
2 clinical trials
2 products
Product
[89Zr]Zr-DFO-APACClinical trial
Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC (Phase 0) in Subjects With Peripheral Arterial Occlusive Disease / Critical Limb Ischemia (PAOD/CLI) and Healthy Volunteers - an Open Label PET Study Ealthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography)Status: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
Impact of Nrf2 Activation on Macrovascular Function, Microvascular Function, Leg Function, and Walking Capacity in Patients With Peripheral Artery DiseaseStatus: Not yet recruiting, Estimated PCD: 2025-08-01
Product
Vumerity